arXiv Machine Learning By Kai Dahms, Eilien Heinrich, Jochen Schmid, Michael Bortz, Iryna Savych, Regina Bleul

Accelerating nanodrug development in continuous flow systems using informed prediction models based on low-cost surrogate nanoparticles

Read the original on arXiv Machine Learning →

arXiv:2608. 05761v1 Announce Type: new Abstract: The development of nanotherapeutics often involves extensive empirical optimization due to the sensitivity of nanoparticle properties, such as size and polydispersity index (PDI), to minor changes in process parameters.

Summary generated by The Flow from the publisher's feed. The full article lives at arXiv Machine Learning.

arXiv Machine Learning
Jul 15

Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization

arXiv:2607. 12349v1 Announce Type: new Abstract: Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design.

By Ruoxi Gao, Jiangweizhi Peng, Ziqi Chen, Frazier N. Baker, David C. Kombo, John L. Kane Jr., Andrew A. Scholte, Yi Li, Matthew J. LaMarche, Luigi I. Iconaru, Hans-Peter Biemann, Mingyi Hong, Xia Ning
arXiv Machine Learning
Jul 17

A Machine Learning Benchmarking Framework for Lipid Nanoparticle Transfection Efficiency Prediction

arXiv:2507. 03209v2 Announce Type: replace-cross Abstract: The discovery of new ionizable lipids for efficient lipid nanoparticle (LNP)-mediated RNA delivery remains a major bottleneck in RNA therapeutics development.

By Asal Mehradfar, Mohammad Shahab Sepehri, Jose Miguel Hernandez-Lobato, Glen S. Kwon, Mahdi Soltanolkotabi, Salman Avestimehr, Morteza Rasoulianboroujeni